德国银屑病疾病成本横断面研究
该研究从社会视角评估德国银屑病年度成本,2013/2014年在随机选取的皮肤科诊所和医院开展横断面调查,采用疾病相关成本标准化问卷;共纳入132个中心的1158例完整数据患者。患者年均总成本为5543±8044欧元,系统治疗成本(由法定医疗保险支付)为3733±7322欧元。
要点
- 银屑病患者年均总成本为5543±8044欧元,经济负担显著
- 系统治疗成本(法定医保支付)为3733±7322欧元,是主要成本构成
- 2003至2014年间成本从住院、自付和间接成本明显转向系统药物成本
核心结论
- 银屑病造成相当大的经济负担。
- 2003至2014年间,成本从住院、自付和间接成本明显转向系统药物成本。
研究设计与样本
- 2013/2014年在随机选取的德国皮肤科诊所和医院开展横断面研究。
- 采用疾病相关成本标准化问卷,从社会视角评估年度成本。
- 完整数据来自132个中心的1158例患者。
主要发现
- 患者年均总成本为5543±8044欧元。
- 系统治疗成本(由法定医疗保险支付)为3733±7322欧元。
- 自付成本为224±406欧元,法定医疗保险总成本为4940±7533欧元。
- 直接成本为5164±7581欧元,间接成本为379±2087欧元。
- 男性成本显著更高,65岁及以上患者成本显著更低。
临床怎么用
- 结果提示银屑病经济负担可观,成本构成已向系统药物倾斜。
- 评估患者负担时需同时考虑直接成本、自付成本和间接成本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Though psoriasis poses a substantial chronic socio-economic burden, few studies have addressed the economic impact in Germany. OBJECTIVES: The objective was to evaluate the annual costs of psoriasis in Germany from the societal perspective. METHODS: A cross-sectional study was performed in randomly selected German dermatology practices and clinics in 2013/2014 using standardized questionnaires of illness-related costs. Costs were grouped by perspective and category as well as analysed by sex and age. Group differences were tested by non-parametric tests. RESULTS: Complete data were obtained from 1158 patients in 132 centres. Annual average costs for patients with psoriasis: total costs € 5543 ± € 8044, systemic treatment costs (paid by the statutory health insurances [SHI]) € 3733 ± € 7322, out-of-pocket costs € 224 ± € 406, total SHI costs € 4940 ± € 7533, direct costs € 5164 ± € 7581 and indirect costs € 379 ± € 2087. Significant higher costs in male and significant lower costs in 65+-year-old patients were found. CONCLUSIONS: Psoriasis induces a considerable economic burden. Between 2003 and 2014, costs have markedly shifted from hospital, out-of-pocket and indirect costs towards systemic drug costs.
引用
- Jungen D, Augustin M, Langenbruch A, et al. Cost-of-illness of psoriasis - results of a German cross-sectional study. J Eur Acad Dermatol Venereol. 2017. PMID: 28857297. doi:10.1111/jdv.14543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。